Categories Earnings, Retail

Diet Coke brings fizz back to Coca-Cola in Q1

Coca-Cola (KO) reported better-than-expected first quarter results before the opening bell today. Adjusted earnings came in at $0.47 per share, which topped Wall Street estimates. Reported net profits rose 16% to $1.37 billion, primarily driven by improved sales from its Diet Coke and Coke Zero brands.

Unit volumes improved 3% during the quarter led by coffee and tea (5%) as well as sparkling drinks (4%). Organic revenues saw 5% improvement aided by growth in concentrates and better price/mix. As expected, GAAP revenues were down 16% due to the refranchising activities in North America. Operating margins on a GAAP basis improved 220 basis points to 23.75%, while adjusted margins came in at 30.65%, up 600 basis points.

As customers are shifting towards healthier options, Coca-Cola and its peers had witnessed their soda sales dwindling over the years. It’s worth noting that sugary soft drinks have been contributing a lion’s share to the beverage giant. The company saw the transition happening amongst consumers and responded to it immediately. In January, it launched Diet Coke with four new flavors. The new product came in with brand-new packaging, which was more appealing to millennials. Diet Coke saw volume growth in North America for the first time after a lull of nearly 8 years.

Coca-Cola First Quarter 2018 Earnings

Last year, the company launched Coca-Cola Zero Sugar, which has been selling well for the past two quarters. In North America, the beverage giant’s biggest market, Coke Zero Sugar posted double-digit growth in the quarter. Product revamp done by the company in line with customer expectations seem to be bearing fruit. The world’s largest beverage company said it on the right path to achieve its full year outlook.

The company also has been diversifying its portfolio more attuned to the taste of consumers. In North America, it has posted double-digit growth in water brands Dasani and smartwater. During the quarter, Coke launched Fuze Tea in Europe, which was already available in other parts of the world. Coke is looking to acquire new brands, which would augur well in the long-term.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top